The Effects of Dance for Breast Cancer Patients Undergoing Surgical Treatment
Os Efeitos da dança Como Recurso terapêutico em Pacientes Com câncer de Mama Submetidas a Tratamento cirúrgico
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this non randomized clinical trial, with pre- and post-intervention evaluation, longitudinal, with prospective data collection is to evaluate the effects of dance as a therapeutic intervention in breast cancer patients undergoing surgical treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2024
CompletedFirst Posted
Study publicly available on registry
January 22, 2024
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
ExpectedJanuary 28, 2025
January 1, 2025
1.9 years
January 8, 2024
January 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
ROM
Shoulder range of motion
Pre-intervention and after 16 weeks
Secondary Outcomes (6)
Overall muscle strength
Pre-intervention and after 16 weeks
Fatigue
Pre-intervention and after 16 weeks
respiratory muscle strength
Pre-intervention and after 16 weeks
Functionality
Pre-intervention and after 16 weeks
Pain intensity
Pre-intervention and after 16 weeks
- +1 more secondary outcomes
Study Arms (1)
Dance
EXPERIMENTALDance
Interventions
Eligibility Criteria
You may qualify if:
- patients diagnosed with breast cancer
- undergone surgical resection
- after medical referral for physiotherapy
- and physiotherapeutic assessment
You may not qualify if:
- patients with another previous oncological diagnosis
- previous neuromuscular diseases
- patients who do not agree to take part in the study
- or the impossibility of carrying out the muscle strength assessment and/or other assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AC Camargo Cancer Center
São Paulo, 01525-001, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Letícia Cardenas, PHD
AC Camargo Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Single group
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PHD, physiotherapist at the intensive care unit, stricto sensu postgraduate professor
Study Record Dates
First Submitted
January 8, 2024
First Posted
January 22, 2024
Study Start
February 1, 2024
Primary Completion
December 10, 2025
Study Completion (Estimated)
May 30, 2026
Last Updated
January 28, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share